Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project

Published:2011-03-23 Issue:5 Volume:20 Page:497-505
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Franchi Carlotta¹,Lucca Ugo²,Tettamanti Mauro²,Riva Emma²,Fortino Ida³,Bortolotti Angela³,Merlino Luca³,Pasina Luca¹,Nobili Alessandro¹

Affiliation:

1. Laboratory for Quality Assessment of Geriatric Therapies and Services; Mario Negri Institute for Pharmacological Research; Milan; Italy

2. Laboratory of Geriatric Neuropsychiatry; Mario Negri Institute for Pharmacological Research; Milan; Italy

3. Regional Health Ministry; Lombardy Region; Milan; Italy

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference42 articles.

1. Worldwide prevalence and incidence of dementia;Fratiglioni;Drugs Aging,1999

2. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease;Davis;N Engl J Med,1992

3. A controller trial of tacrine in Alzheimer's disease;Farlow;JAMA,1992

4. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease;Knapp;JAMA,1994

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants;Degenerative Neurological and Neuromuscular Disease;2024-05

2. Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data;Current Medical Research and Opinion;2023-03-11

3. Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer disease;Metabolic Brain Disease;2023-01-18

4. Network pharmacology and bioinformatics approach reveals the therapeutic activity and action mechanism of curcumin in Alzheimer disease;2022-10-10

5. Antibiotic use and associated factors in adult outpatients from 2000 to 2019;Pharmacology Research & Perspectives;2021-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3